REFERENCES
- Chow , S. C. , Shao , J. , Hu , O. Y. P. ( 2002 ). Assessing sensitivity and similarity in bridging studies . Journal of Biopharmaceutical Statistics 12 : 385 – 400 .
- Chung-Stein , C. , Anderson , K. , Gallo , P. , Collins , S. ( 2006 ). Sample size reestimation: a review and recommendations . Drug Information Journal 40 : 475 – 484 .
- Church , J. D. , Harris , B. ( 1970 ). The estimation of reliability from stress-strength relationships . Technometrics 12 : 49 – 54 .
- Cui , L. , Hung , H. M. J. , Wang , S. J. ( 1999 ). Modification of sample size in group sequential trials . Biometrics 12 : 853 – 857 .
- Enis , P. , Geisser , S. ( 1971 ). Estimation of the probability that Y < X . Journal of American Statistical Association 66 : 162 – 168 .
- Friede , T. , Kieser , M. ( 2004 ). Sample size recalculation for binary data in internal pilot study designs . Pharmaceutical Statistics 3 : 269 – 279 .
- Hsiao , C. F. , Hsu , Y. Y. , Tsou , H. H. , Liu , J. P. ( 2007 ). Use of prior information for Bayesian evaluation of bridging studies . Journal of Biopharmaceutical Statistics 17 : 109 – 121 .
- Hung , H. M. J. , Cui , L. , Wang , S. J. , Lawrence , J. ( 2005 ). Adaptive statistical analysis following sample size modification based on interim review of effect size . Journal of Biopharmaceutical Statistics 15 : 693 – 706 .
- International Conference on Harmonisation . ( 1998 ). Tripartite guidance E5, Ethnic factors in the acceptability of foreign data . Federal Register 83 : 31790 – 31796 .
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use . ( 2006 ). Q&A for the ICH E5 Guldeline on Ethnic Factors in the Acceptability of Foreign Data . Available at: http:// www.ich.org/LOB/media/MEDIA 1194.pdf .
- Kawai , N. , Stein , C. , Komiyama , O. , Li , Y. ( 2008 ). An approach to rationalize partitioning sample size into individual regions in a multiregional trial . Drug Information Journal 42 : 139 – 147 .
- Lan , G. K. K. , Soo , Y. W. , Siu , C. T. , Wang , M. ( 2005 ). The use of weighted Z-tests in medical research . Journal of Biopharmaceutical Statistics 15 ( 4 ): 625 – 639 .
- Liu , J. P. , Hsiao , C. F. , Hsueh , H. M. ( 2002 ). Bayesian approach to evaluation of bridging studies . Journal of Biopharmaceutical Statistics 12 : 401 – 408 .
- Liu , J. P. , Hsueh , H. M. , Chen , J. J. ( 2002 ). Sample size requirement for evaluation of bridging evidence . Biometrical Journal 44 : 969 – 981 .
- Liu , Q. , Chi , G. Y. H. ( 2001 ). On sample size and inference for two-stage adaptive designs . Biometrics 57 : 172 – 177 .
- Ministry of Health, Labor, and Welfare of Japan . ( 2007 ). Basic Principles on Global Clinical Trials . Tokyo : MHLW .
- Posch , M. , Bauer , P. ( 1999 ). Adaptive two-stage designs and the conditional error function . Biometrical Journal 41 : 689 – 696 .
- Proschan , M. A. ( 2005 ). Two-stage sample size re-estimation based on a nuisance parameter: a review . Journal of Biopharmaceutical Statistics 15 : 539 – 574 .
- Proschan , M. A. , Hunsberger , S. A. ( 1995 ). Designed extension of studies based on conditional power . Biometrics 51 : 1315 – 1324 .
- Shih , W. J. ( 2001 ). Clinical trials for drug registration in Asian-Pacific countries: Proposal for a new paradigm from a statistical perspective . Controlled Clinical Trials 22 : 357 – 366 .
- Shih , W. J. ( 2006 ). Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison . Statistics in Medicine 25 : 933 – 941 .